H2C advises Rizk Ventures on Colombia, South America hospital acquisition


Hammond Hanlon Camp LLC (“H2C”), a healthcare-focused investment banking firm, served as the exclusive financial advisor to Rizk Ventures Colombia (“Rizk”), a New York-based private investment firm, on the structure of a joint venture to acquire the Instituto del Corazon Floridablanca hospital (“ICF”) located in Bucaramanga, Colombia, from Fundación Cardiovascular de Colombia (“FCV”).

H2C was engaged by Rizk to identify a capital partner, structure a joint venture (“JV”) and assist the JV in the acquisition and development of a portfolio of acute-care hospital facilities located throughout Colombia, South America.  H2C conducted an extensive marketing effort, which resulted in the selection of Goldman Sachs as the partner for the transaction.  H2C advised Rizk in structuring the terms of the JV agreement and the sale/leaseback transaction with FCV.

“H2C was very pleased to have the opportunity to assist Rizk Ventures with the capitalization of this exciting international investment and build upon the long-standing relationship between our firms,” said Michael B. Hammond, Principal of H2C.  Email Michael

Completed in 1997, ICF is a 197-bed hospital located in Bucaramanga. ICF was the first hospital in Colombia to receive international accreditation for meeting various quality and safety standards by the Joint Commission International.  In 2014, Latin American business magazine, América Economia, ranked ICF as the #1 hospital in Colombia and the #4 hospital in Latin America.  The hospital will continue to be operated by FCV, a non-profit healthcare system founded in 1986 and one of the ten largest hospital operators in Latin America with various locations throughout Colombia and a partnership with the University of Pittsburgh.

The acquisition in Bucaramanga is the first of a number of potential acquisitions and developments being evaluated for investment by the JV over the next 12 to 18 months.

“With only 1.5 hospital beds per 1,000 people in Colombia today, hospital development and expansion is expected to increase over the next several years,” said Jay Miele, Managing Director of H2C. “Rizk Ventures Colombia represents a qualified and experienced sponsor which, when combined with Goldman Sachs, creates a formidable vehicle for growth in the Colombian hospital sector.”  Email Jay

“We chose H2C to advise us on this transaction because of the firm’s focus on healthcare and depth of experience in real estate,” said Klaus Lederer, Managing Partner of Rizk Ventures. “We are extremely happy with the new venture they facilitated for us, which is poised for significant near-term growth,” commented Geoff Rizk, Managing Partner of Rizk Ventures.

 For more information, go to h2c.com.

 

 

 

 



March 28, 2016


Topic Area: Press Release


Recent Posts

Waco Family Medicine Achieves Savings and Bold Design with Wood Selections

Case study: The healthcare facility incorporated over 25,000 square feet of wood and saved over $400,000.


Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.